{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:12:30Z","timestamp":1775560350586,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through \nthe European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise the public health benefit of available vaccines, there is a pressing need to vaccinate a large proportion of the population. Internationally, this has prompted coordination of existing services at enormous scale, and development and implementation of novel vaccination strategies to ensure maximum inoculation over the shortest possible timeframe. Pharmacists are being promoted as healthcare professionals that enhance roll-out of COVID-19 vaccination programmes. This paper aims to summarise current policy and practice in relation to pharmacists\u2019 involvement in COVID-19 vaccination in 13 countries across Europe.<\/jats:p>","DOI":"10.1007\/s11096-021-01301-7","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T17:02:31Z","timestamp":1625331751000},"page":"1139-1148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Pharmacists\u2019 involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4173-6490","authenticated-orcid":false,"given":"Vibhu","family":"Paudyal","sequence":"first","affiliation":[]},{"given":"Daniela","family":"Fialov\u00e1","sequence":"additional","affiliation":[]},{"given":"Martin C.","family":"Henman","sequence":"additional","affiliation":[]},{"given":"Ankie","family":"Hazen","sequence":"additional","affiliation":[]},{"given":"Betul","family":"Okuyan","sequence":"additional","affiliation":[]},{"given":"Monika","family":"Lutters","sequence":"additional","affiliation":[]},{"given":"Cathal","family":"Cadogan","sequence":"additional","affiliation":[]},{"given":"Filipa Alves","family":"da Costa","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Galfrascoli","sequence":"additional","affiliation":[]},{"given":"Yvonne Marina","family":"Pudritz","sequence":"additional","affiliation":[]},{"given":"Silas","family":"Rydant","sequence":"additional","affiliation":[]},{"given":"Jaime","family":"Acosta-G\u00f3mez","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"key":"1301_CR1","unstructured":"Ghebreyesus TA. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19-2020. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 12 Apr\u00a02021."},{"key":"1301_CR2","unstructured":"WHO Coronavirus (COVID-19). Dashboard. https:\/\/covid19.who.int. Accessed 12 Apr\u00a02021."},{"key":"1301_CR3","unstructured":"European Medicines Agency. COVID-19 vaccines. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/covid-19-vaccines. Accessed 12 Apr\u00a02021."},{"key":"1301_CR4","unstructured":"European Medicines Agency. COVID-19 vaccines: authorised. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/covid-19-vaccines-authorised. Accessed 12 Apr\u00a02021."},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2020.04.012","volume":"52","author":"HE Randolph","year":"2020","unstructured":"Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52:737\u201341.","journal-title":"Immunity"},{"issue":"1","key":"1301_CR6","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.sapharm.2020.08.020","volume":"17","author":"D Dawoud","year":"2021","unstructured":"Dawoud D, Chen AM, Rossing CV, Garcia-Cardenas V, Law AV, Aslani P, et al. Pharmacy practice research priorities during the COVID-19 pandemic: recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group. Res Soc Admin Pharm. 2021;17(1):1903\u20137.","journal-title":"Res Soc Admin Pharm"},{"key":"1301_CR7","first-page":"1 1819","volume":"17","author":"SQ Zheng","year":"2021","unstructured":"Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Soc Admin Pharm. 2021;17:1 1819\u201324.","journal-title":"Res Soc Admin Pharm"},{"issue":"1","key":"1301_CR8","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.sapharm.2020.07.001","volume":"17","author":"ES Koster","year":"2021","unstructured":"Koster ES, Philbert D, Bouvy ML. Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Soc Admin Pharm. 2021;17(1):2002\u20134.","journal-title":"Res Soc Admin Pharm"},{"key":"1301_CR9","unstructured":"Centre for disease control and prevention. Understanding the Federal Retail Pharmacy Program for COVID-19 Vaccination. https:\/\/www.cdc.gov\/vaccines\/covid-19\/retail-pharmacy-program\/index.html. Accessed 14 June 2021."},{"key":"1301_CR10","unstructured":"General Pharmaceutical Council. COVID-19 vaccination programme. https:\/\/www.pharmacyregulation.org\/standards\/guidance\/qa-coronavirus\/covid-19-vaccination-programme. Accessed 12 Apr\u00a02021."},{"key":"1301_CR11","unstructured":"Royal Pharmaceutical Society. COVID-19 vaccines. https:\/\/www.rpharms.com\/resources\/pharmacy-guides\/coronavirus-covid-19\/covid-19-vaccines. Accessed 12 Apr\u00a02021."},{"issue":"8","key":"1301_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.sapharm.2020.11.017","volume":"17","author":"V Paudyal","year":"2021","unstructured":"Paudyal V, Cadogan C, Fialov\u00e1 D, Henman MC, Hazen A, Okuyan B, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Res Soc Adm Pharm. 2021;17(8):1507\u201317.","journal-title":"Res Soc Adm Pharm"},{"issue":"12","key":"1301_CR13","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1080\/21645515.2016.1215393","volume":"12","author":"RC Burson","year":"2016","unstructured":"Burson RC, Buttenheim \nAM, Armstrong A, Feemster KA. Community pharmacies as sites of adult vaccination: a systematic review. Hum Vaccin Immunother. 2016;12(12):3146\u201359.","journal-title":"Hum Vaccin Immunother"},{"key":"1301_CR14","unstructured":"Announcement and call of the project. Vaccination against flu in pharmacies in 2020. Croatian Pharmaceutical Chamber (23.9.2020).\u00a0https:\/\/www.hljk.hr\/Vijesti\/tabid\/37\/ctl\/Details\/mid\/4861\/ItemID\/6594\/Default.aspx. Accessed 31 Mar\u00a02021."},{"key":"1301_CR15","doi-asserted-by":"publisher","unstructured":"Novak H, Tadi\u0107 I, Falami\u0107 S, Ortner Had\u017eiabdi\u0107 M, Pharmacists\u2019 role, work practices, and safety measures against COVID-19: a comparative study. J Am Pharm Assoc. 2021. https:\/\/doi.org\/10.1016\/j.japh.2021.03.006.","DOI":"10.1016\/j.japh.2021.03.006"},{"key":"1301_CR16","unstructured":"\u201cPozovi za zdravlje\u201c POZIVNI CENTAR HRVATSKE LJEKARNI\u010cKE KOMORE. (17.4.2020). \u00a0https:\/\/www.hljk.hr\/Vijesti\/tabid\/37\/ctl\/Details\/mid\/4861\/ItemID\/6416\/Default.aspx. Accessed 14 Apr\u00a02021."},{"key":"1301_CR17","unstructured":"Z\u00e1kony pro lidi. Vyhl. 92\/2012 Sb. o po\u017eadavc\u00edch na minim\u00e1ln\u00ed technick\u00e9 a v\u011bcn\u00e9 vybaven\u00ed zdravotnick\u00fdch za\u0159\u00edzen\u00ed a kontaktn\u00edch pracovi\u0161\u0165 dom\u00e1c\u00ed p\u00e9\u010de. (Laws for People. Decree 92\/1992 Coll. about requirements of minimal technical and material equipment of the health care facilities and contact centres for home care). https:\/\/www.zakonyprolidi.cz\/cs\/2012-92. Accessed 30 Mar\u00a02021."},{"key":"1301_CR18","unstructured":"Co si l\u00e9k\u00e1rn\u00edci mysl\u00ed o o\u010dkov\u00e1n\u00ed proti COVID-19?. (What pharmacists think about vaccination against COVID-19?). https:\/\/www.facebook.com\/lekarnici\/videos\/1361151524236879\/. Accessed 30 Mar\u00a02021."},{"key":"1301_CR19","unstructured":"Schersch S. BMG empfiehlt Einsatz von Apothekern in Impfzentren. PZ online, published 17.11.2020, https:\/\/www.pharmazeutische-zeitung.de\/bmg-empfiehlt-einsatz-von-apothekern-in-impfzentren-121880\/. [German] Accessed 25 Mar\u00a02021."},{"key":"1301_CR20","unstructured":"Bundesgesundheitsministerium. Verordnung zum Anspruch auf Schutzimpfung gegen das Coronavirus SARS-CoV-2 (Coronavirus-Impfverordnung-CoronaImpfV). Banz AT 08.02.2021."},{"key":"1301_CR21","unstructured":"Evans J. Heilberufliche Aufgaben: Das d\u00fcrfen Apotheker anderswo \u2013 auch ein Weg f\u00fcr Deutschland? PZ Online, published 25.3.2021, available at https:\/\/www.pharmazeutische-zeitung.de\/das-duerfen-apotheker-anderswo-auch-ein-weg-fuer-deutschland-124621\/. [German] Accessed 25 Mar\u00a02021."},{"key":"1301_CR22","unstructured":"Die Bundesregierung. FAQ Die wichtigsten Fragen und Antworten zur Corona-Impfung: Wird auch in Hausarztpraxen geimpft?\u00a0https:\/\/www.bundesregierung.de\/breg-de\/themen\/coronavirus\/coronavirus-impfung-faq-1788988#tar-4. [German] Accessed 25 Mar\u00a02021."},{"key":"1301_CR23","unstructured":"Celine M\u00fcller. ADKA sorgt f\u00fcr ausreichend Midazolam w\u00e4hrend Corona-Pandemie. DAZ online, published 7.7.2020. https:\/\/www.deutsche-apotheker-zeitung.de\/news\/artikel\/2020\/07\/07\/adka-sorgt-fuer-ausreichend-midazolam-waehrend-corona-pandemie\/chapter:all [German] Accessed 25 Mar\u00a02021."},{"key":"1301_CR24","unstructured":"M\u00fcller C. Antigentest in der Apotheke \u2013 was Apotheker jetzt wissen m\u00fcssen. DAZ online, published 24.02.2021, available at https:\/\/www.deutsche-apotheker-zeitung.de\/news\/artikel\/2021\/02\/24\/antigentests-in-der-apotheke-was-apotheker-jetzt-wissen-muessen. [German] Accessed 25 Mar\u00a02021."},{"key":"1301_CR25","unstructured":"Robert-Koch-Institut. COVID-19: Klinische Daten. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/ZS\/klinischeDaten.html;jsessionid=497969B194E6655D7574132176E18A30.internet081?nn=13490888. [German] Accessed 25 Mar 2021."},{"key":"1301_CR26","unstructured":"Pharmaceutical Society of Ireland. Guidance on the Provision of Vaccination Services by Pharmacists in Retail Pharmacy Businesses; Pharmaceutical Society of Ireland: Dublin, Ireland. 2019. https:\/\/www.thepsi.ie\/Libraries\/Folder_Pharmacy_Practice_Guidance\/PPGF_02_8_Guidance_on_the_Provision_of_Vaccination_Services_by_Pharmacists_in_a_Retail_Pharmacy_Businesses.sflb.ashx. Accessed 12 Apr\u00a02021."},{"key":"1301_CR27","unstructured":"Government of Ireland. Medicinal Products (Prescription and Control of Supply) (Amendment) (No.5) Regulations (S.I. No. 401 of 2020). 2020. Office of the Attorney General, Ireland. https:\/\/www.irishstatutebook.ie. Accessed 12 Apr\u00a02021."},{"key":"1301_CR28","unstructured":"Government of Ireland. Medicinal Products (Prescription and Control of Supply) (Amendment) (No.7) Regulations (S.I. 698 of 2020). 2020. Office of the Attorney General, Ireland. https:\/\/www.irishstatutebook.ie. Accessed 12 Apr\u00a02021."},{"key":"1301_CR29","doi-asserted-by":"crossref","unstructured":"Department of Health (Ireland). National COVID-19 Vaccination Programme: Strategy. 2020. Department of Health, Ireland. https:\/\/www.gov.ie\/en\/publication\/bf337-covid-19-vaccination-strategy-and-implementation-plan\/. Accessed 12 Apr\u00a02021.","DOI":"10.22359\/cswhi_12_2_05"},{"key":"1301_CR30","unstructured":"Department of Health (Ireland). National COVID-19 Vaccination Programme: Implementation Plan. 2020. Department of Health, Ireland. https:\/\/www.gov.ie\/en\/publication\/bf337-covid-19-vaccination-strategy-and-implementation-plan\/. Accessed 12 Apr\u00a02021."},{"key":"1301_CR31","unstructured":"Griffin N. \u2018Pharmacy Covid-19 vaccinations to start in April\u2019. The Irish Examiner. 2021. Published: 06.03.21. https:\/\/www.irishexaminer.com\/news\/arid-40238894.html?utm_source=dlvr.it&utm_medium=twitter. Accessed 12 Apr\u00a02021."},{"key":"1301_CR32","unstructured":"Health Service Executive. Circular Number: NCO-03-2021 Arrangement with Pharmacists in Context of Roll Out of Covid-19 Vaccination Programme. 21 January, 2021. www.hse.ie\/eng\/staff\/pcrs\/circulars\/pharmacy\/pharmacy-circular-vaccination-programme-nco-03-2021.pdf. Accessed 14 June 2021."},{"key":"1301_CR33","unstructured":"Pharmaceutical Services Negotiating Committee. COVID-19 vaccinations https:\/\/psnc.org.uk\/the-healthcare-landscape\/covid19\/covid-19-vaccinations\/. Accessed 20 Apr\u00a02021."},{"key":"1301_CR34","unstructured":"NHS England. Community pharmacy local enhanced service\u2013coronavirus vaccination. COVID-19 vaccination programme 2020\/21. https:\/\/www.england.nhs.uk\/coronavirus\/wp-content\/uploads\/sites\/52\/2020\/12\/C1197-community-pharmacy-local-enhanced-service-coronavirus-vaccination-v3-.pdf. Accessed 14 June 2021."},{"issue":"3","key":"1301_CR35","doi-asserted-by":"publisher","first-page":"e0193286","DOI":"10.1371\/journal.pone.0193286","volume":"13","author":"T Noblet","year":"2018","unstructured":"Noblet T, Marriott J, Graham-Clarke E, Shirley D, Rushton A. Clinical and cost-effectiveness of non-medical prescribing: a systematic review of randomised controlled trials. PLoS ONE. 2018;13(3):e0193286.","journal-title":"PLoS ONE"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-021-01301-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:31:23Z","timestamp":1628537483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-021-01301-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s11096-021-01301-7","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"20 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Vibhu Paudyal (VP) and Filipa Alves da Costa (FAC) are associate editors of the International Journal of Clinical Pharmacy. VP and FAC had no role in handling the manuscript, specifically the processes of editorial review, peer review and decision making.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}